Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Abroad (travel likely)RecruitingPHASE1
Conditions
Sickle Cell Disease · Executive Dysfunction · Cognitive Impairment · Attention Deficit/Hyperactivity Disorder (ADHD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Andrew K Heitzer, PhD)
Study leads
Andrew W. Heitzer, PhD
Principal Investigator
St. Jude Children's Research Hospital